SCHEMBL10148712

SCHEMBL10148712

Cc1nc(N)c2ncc([C@]3(C#N)O[C@H](CO[PH](O)(NCc4ccccc4)OCCSC(=O)C(C)(C)CO)[C@@H](O)[C@@]3(C)F)n2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14996129 0.95 — —
SCHEMBL12397153 0.86 — —
SCHEMBL18214612 0.81 — —
SCHEMBL12761526 0.81 — —
SCHEMBL12393479 0.80 — —
SCHEMBL12393317 0.75 — —
SCHEMBL10148703 0.72 — —
SCHEMBL10149732 0.71 — —
SCHEMBL10148662 0.69 — —
SCHEMBL19997409 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455451-B2 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2013-06-04 — — US disclosed
US-20120009147-A1 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2012-01-12 — — US disclosed
Send feedback